AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Nov 4, 2015
29828_dirs_2015-11-04_a2843826-91ec-4b48-b89e-34c782910356.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-11-02
Reporting Person: MARTIN JOHN C (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-02 | Common Stock | M | 150000 | $14.5025 | Acquired | 4098066 | Direct |
| 2015-11-02 | Common Stock | S | 42417 | $109.0176 | Disposed | 4055649 | Direct |
| 2015-11-02 | Common Stock | S | 107583 | $109.5789 | Disposed | 3948066 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-02 | Non-Qualified Stock option (right to buy) | $14.5025 | M | 150000 | Disposed | 2016-01-25 | Common Stock (150000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $108.40 to $109.40. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $109.41 to $109.93. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.